What is the true prevalence of EGFR mutations in India?

被引：1
|
作者：
Jiwnani, Sabita [1 ]
Karimundackal, George [1 ]
Pramesh, C. S. [1 ]
Prabhash, Kumar [2 ]
机构：
[1] Tata Mem Hosp, Dept Surg Oncol, Div Thorac Surg & Oncol, Bombay 400012, Maharashtra, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay 400012, Maharashtra, India
来源：
LUNG CANCER | 2011年 / 74卷 / 03期
关键词：
EGFR mutation; Prevalence; GEFITINIB;
D O I：
10.1016/j.lungcan.2011.09.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：549 / 549
页数：1
相关论文
共 50 条
  • [41] EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
    Arcila, Maria E.
    Nafa, Khedoudja
    Chaft, Jamie E.
    Rekhtman, Natasha
    Lau, Christopher
    Reva, Boris A.
    Zakowski, Maureen F.
    Kris, Mark G.
    Ladanyi, Marc
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (02) : 220 - 229
  • [42] The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus Richter
    Sorensen, Jens Benn
    Skov, Torsten
    Mellemgaard, Anders
    APMIS, 2015, 123 (02) : 108 - 115
  • [43] SCREENING FOR THE PREVALENCE OF EGFR AND ALK MUTATIONS IN LUNG ADENOCARCINOMA PATIENTS IN THE LEVANT AREA, A PROSPECTIVE ANALYSIS
    Tfayli, A.
    Khalil, M.
    Mina, A.
    Rafei, H.
    Fakhreddin, N.
    Mahfouz, R.
    Farhat, F.
    Hamouri, S.
    Dbouk, H.
    Zaatari, G.
    ANNALS OF ONCOLOGY, 2015, 26
  • [44] No, EGFR TKIs Should Be Reserved for Patients With EGFR Mutations
    Riely, Gregory J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 41 - +
  • [45] Screening for the prevalence of EGFR and ALK mutations in lung adenocarcinoma patients in the levant area, a prospective analysis
    Tfayli, A.
    Rafei, H.
    Khalil, M.
    Mina, A.
    Fakhreddin, N.
    Mahfouz, R.
    Farhat, F.
    Rabee, H.
    Hamouri, S.
    Dbouk, H.
    Salem, Z.
    Saghir, N.
    Shamseddine, A.
    Bitar, N.
    Mougharbil, A.
    Makarem, J.
    Daw, W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S30 - S31
  • [46] What Is the True Incidence and Prevalence of Myasthenia Gravis? A Systematic Review of Myasthenia Gravis Epidemiology
    Fitzpatrick, Aisling S.
    Cardwell, Chris
    McCarron, Peter
    McConville, John P.
    NEUROLOGY, 2009, 72 (11) : A467 - A467
  • [47] Prevalence of mutations in inherited retinal diseases: A comparison between the United States and India
    Yohe, Sophia
    Sivasankar, Malaichamy
    Ghosh, Anuprita
    Ghosh, Arkasubhra
    Holle, Jennifer
    Murugan, Sakthivel
    Gupta, Ravi
    Schimmenti, Lisa A.
    Vedam, Ramprasad
    Thyagarajan, Bharat
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (02):
  • [48] Assessing EGFR mutations -: Reply
    Tsao, MS
    Kamel-Reid, S
    Shepherd, FA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05): : 527 - 528
  • [49] EGFR mutations and sensitivity to gefitinib
    Rossi, G
    Marchioni, A
    Longo, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (12): : 1260 - 1261
  • [50] EGFR Mutations and Lung Cancer
    Santos, Gilda da Cunha
    Shepherd, Frances A.
    Tsao, Ming Sound
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6, 2011, 6 : 49 - 69
12345